NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study : vimarsana.com

NAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy Neuromodulation therapy is not currently...

Related Keywords

United States , Martha Morrell , Jeremy Feffer , Epilepsy Center , Globenewswire Inc , Nasdaq , Exchange Commission , Neuropace Inc , Drug Administration , Chief Medical , Comprehensive Epilepsy Center , Investigational Device Exemption , Device Designation , Financial Condition , Annual Report , Quarterly Report , Markets ,